SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Minthon L) ;pers:(Tsolaki Magda)"

Sökning: WFRF:(Minthon L) > Tsolaki Magda

  • Resultat 1-4 av 4
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • van Rossum, Ineke A, et al. (författare)
  • Injury markers predict time to dementia in subjects with MCI and amyloid pathology.
  • 2012
  • Ingår i: Neurology. - 1526-632X. ; 79:17, s. 1809-16
  • Tidskriftsartikel (refereegranskat)abstract
    • Alzheimer disease (AD) can now be diagnosed in subjects with mild cognitive impairment (MCI) using biomarkers. However, little is known about the rate of decline in those subjects. In this cohort study, we aimed to assess the conversion rate to dementia and identify prognostic markers in subjects with MCI and evidence of amyloid pathology.
  •  
2.
  •  
3.
  • Jacobs, Heidi I. L., et al. (författare)
  • The association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent
  • 2012
  • Ingår i: Neurobiology of Aging. - : Elsevier BV. - 1558-1497 .- 0197-4580. ; 33:1, s. 1-201
  • Tidskriftsartikel (refereegranskat)abstract
    • White matter hyperintensities (WMH) in Mild Cognitive Impairment (MCI) have been associated with impaired executive functioning, although contradictory findings have been reported. The aim of this study was to examine whether WMH location influenced the relation between WMH and executive functioning in MCI participants (55-90 years) in the European multicenter memory-clinic-based DESCRIPA study, who underwent MRI scanning at baseline (N = 337). Linear mixed model analysis was performed to test the association between WMH damage in three networks (frontal-parietal, frontal-subcortical and frontal-parietal-subcortical network) and change in executive functioning over a 3-year period. WMH in the frontal-parietal and in the frontal-parietal-subcortical network were associated with decline in executive functioning. However, the frontal-subcortical network was not associated with change in executive functioning. Our results suggest that parietal WMH are a significant contributor to executive decline in MCI and that investigation of WMH in the cerebral networks supporting cognitive functions provide a new way to differentiate stable from cognitive declining MCI individuals. (C) 2012 Elsevier Inc. All rights reserved.
  •  
4.
  • Visser, Pieter Jelle, et al. (författare)
  • Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
  • 2009
  • Ingår i: Lancet neurology. - : The Lancet Publishing Group. - 1474-4422 .- 1474-4465. ; 8:7, s. 619-27
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Alzheimer's disease (AD) pathology is common in patients with amnestic mild cognitive impairment (aMCI) without dementia, but the prevalence of AD pathology in patients with subjective cognitive impairment (SCI) and non-amnestic mild cognitive impairment (naMCI) is unknown. AD is characterised by decreased CSF concentrations of Abeta(42) and increased concentrations of tau. We investigated the prevalence of a CSF AD profile in patients with SCI, naMCI, or aMCI and the association of this profile with cognitive outcome in each group. METHODS: Patients with SCI, naMCI, aMCI, and neurologically healthy controls were recruited from 20 memory clinics across Europe, between January, 2003, and June, 2005, into this prospective cohort study. A CSF AD profile was defined as an abnormal ratio of Abeta(42):tau. Patients were assessed annually up to 3 years. Outcome measures were changes in memory, overall cognition, mini-mental state examination (MMSE) score, daily function, and progression to AD-type dementia. FINDINGS: The CSF AD profile was more common in patients with SCI (31 of 60 [52%]), naMCI (25 of 37 [68%]), and aMCI (56 of 71 [79%]) than in healthy controls (28 of 89 [31%]). The profile was associated with cognitive decline in patients with naMCI (memory, MMSE, and daily function) and in patients with aMCI (MMSE and daily function). In patients with aMCI, a CSF AD profile was predictive of AD-type dementia (OR 26.8, 95% CI 1.6-456.4). INTERPRETATION: AD is a common cause of SCI, naMCI, and aMCI and is associated with cognitive decline in patients with naMCI or aMCI. Patients with SCI might be in the early stages of AD, and cognitive decline might become apparent only after longer follow-up. FUNDING: European Commission; Ana Aslan International Foundation.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-4 av 4
Typ av publikation
tidskriftsartikel (4)
Typ av innehåll
refereegranskat (4)
Författare/redaktör
Minthon, Lennart (4)
Tsolaki, Magda (4)Ta bort avgränsningen
Scheltens, Philip (4)
Blennow, Kaj, 1958 (3)
Wahlund, Lars-Olof (3)
Soininen, Hilkka (3)
visa fler...
Visser, Pieter Jelle (3)
Hampel, Harald (3)
van der Flier, Wiesj ... (2)
Teunissen, Charlotte ... (2)
Verhey, Frans (2)
Knol, Dirk L. (2)
Zetterberg, Henrik, ... (1)
Wallin, Anders, 1950 (1)
Ingelsson, Martin (1)
Stomrud, Erik (1)
Barkhof, Frederik (1)
Pirttila, Tuula (1)
Martínez-Lage, Pablo (1)
Izagirre, Andrea (1)
Balasa, Mircea (1)
Lleó, Alberto (1)
Frisoni, Giovanni B. (1)
Engelborghs, Sebasti ... (1)
Verbeek, Marcel M (1)
Rueckert, Daniel (1)
Molinuevo, José L (1)
Freund-Levi, Yvonne, ... (1)
Nobili, Flavio (1)
Jacobs, Heidi I. L. (1)
Wallin, Åsa (1)
de Mendonça, Alexand ... (1)
Frölich, Lutz (1)
Hausner, Lucrezia (1)
Wolz, Robin (1)
Ramakers, Inez H. G. ... (1)
Vos, Stephanie J. B. (1)
Rikkert, Marcel Olde (1)
Paquet, Claire (1)
Frolich, Lutz (1)
Skarsgård, Constance (1)
Spiru, Luiza (1)
van Rossum, Ineke A. (1)
Burns, Leah (1)
van de Pol, Laura (1)
Papma, Janne M. (1)
Verhey, Frans R. J. (1)
Struyfs, Hanne (1)
Duits, Flora H (1)
Farotti, Lucia (1)
visa färre...
Lärosäte
Lunds universitet (4)
Göteborgs universitet (3)
Karolinska Institutet  (3)Ta bort avgränsningen
Uppsala universitet (1)
Örebro universitet (1)
Språk
Engelska (4)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (4)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy